Australia markets closed

VRTX Jan 2024 170.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.40000.0000 (0.00%)
As of 03:13PM EST. Market open.
Full screen
Previous close2.4000
Open3.0000
Bid0.0000
Ask8.5000
Strike170.00
Expiry date2024-01-19
Day's range2.4000 - 3.0000
Contract rangeN/A
Volume3
Open interest2
  • Zacks

    Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

    In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $313.57, marking a +0.56% move from the previous day.

  • Motley Fool

    3 Smart Stocks to Buy if a Recession Is on the Way

    Here's why they picked Gilead Sciences (NASDAQ: GILD), Johnson & Johnson (NYSE: JNJ), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (Gilead Sciences): Investors can minimize their risk in the event of a recession by investing in businesses that provide essential products and services and that also pay a dividend to help offset declines in the event of dropping share prices. Gilead Sciences meets both of those criteria, as its HIV treatments are vital to patients.

  • Motley Fool

    The Best Stocks to Invest $5,000 In Right Now

    The stock market has already marked its fair share of high highs and low lows in 2023, and we're not even a full month in. Vertex Pharmaceuticals (NASDAQ: VRTX) isn't one of those healthcare stocks with a massive portfolio of drugs that has tapped out its heyday of superior growth. At present, Vertex has just four approved drugs in its portfolio, and all of them treat the genetic disease cystic fibrosis.